Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Dividend Updates'.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.4 pts less than Nifty Microcap 250 and 7.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jagsonpal Pharmaceuticals' Board of Directors, at a meeting held on May 6, 2025, has recommended a dividend of Rs. 2.5 per equity share (125%) on a face value of Rs. 2 for the financial year ended March 31, 2025. The dividend is subject to approval by shareholders at the upcoming 46th Annual General Meeting. The company has stated that the record date and tentative date of payment for the dividend will be communicated separately.
Shareholders on the record date (to be announced) will be eligible to receive Rs. 2.5 per share as dividend. The announcement signals consistent shareholder returns, though the actual yield depends on the current stock price.